SAMBO, MARGHERITA
 Distribuzione geografica
Continente #
EU - Europa 86
NA - Nord America 31
AS - Asia 9
AF - Africa 2
Totale 128
Nazione #
US - Stati Uniti d'America 31
IT - Italia 27
IE - Irlanda 23
RU - Federazione Russa 15
SE - Svezia 5
SG - Singapore 5
CN - Cina 4
DE - Germania 4
FR - Francia 4
FI - Finlandia 3
GB - Regno Unito 3
CI - Costa d'Avorio 2
NL - Olanda 1
RO - Romania 1
Totale 128
Città #
Dublin 23
Florence 11
Chandler 8
Siena 4
Helsinki 3
Princeton 3
Singapore 3
Abidjan 2
Cernusco sul Naviglio 2
Fairfield 2
New York 2
Shanghai 2
St Louis 2
The Dalles 2
Amsterdam 1
Ashburn 1
Castellina in Chianti 1
Dallas 1
Hounslow 1
Munich 1
Pavia 1
Southend 1
Villa Cortese 1
Washington 1
Totale 79
Nome #
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 70
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 24
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 22
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 11
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 7
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 6
Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease? 5
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 4
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 4
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 4
The infection risk after transjugular intrahepatic portosystemic shunt: A multiple competing risk analysis from a tertiary care center 3
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 3
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 3
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 3
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 3
An eight-year experience of Nocardia infection in Italy: does immunosuppression matter? 3
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 2
Mortality due to COVID-19 during the pandemic: A comparison of first, second and third SMAtteo COvid19 REgistry (SMACORE) 2
SARS Cov-2 infection in a renal-transplanted patient: A case report 2
Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy 2
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 2
Circulating endothelial cells in COVID-19 2
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 2
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 2
Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement 2
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey 2
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 2
Immunity to SARS-CoV-2 up to 15 months after infection 2
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 2
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection 2
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 2
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) 2
Totale 207
Categoria #
all - tutte 1.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 0 0 9 5
2022/202327 2 4 3 8 0 5 1 1 3 0 0 0
2023/202447 1 0 6 7 2 12 11 1 2 1 0 4
2024/2025119 5 6 10 7 91 0 0 0 0 0 0 0
Totale 207